U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Mirum Pharmaceuticals

Market Cap: US$2.2b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Indivior

Market Cap: US$1.1b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Jushi Holdings

Market Cap: US$58.8m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Bavarian Nordic

Market Cap: US$14.1b

Develops, manufactures, and supplies life-saving vaccines.

CureVac

Market Cap: US$1.0b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Esperion Therapeutics

Market Cap: US$168.4m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Day One Biopharmaceuticals

Market Cap: US$646.7m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Amicus Therapeutics

Market Cap: US$1.9b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Vext Science

Market Cap: US$37.2m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Genmab

Market Cap: US$87.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

biote

Market Cap: US$173.6m

Operates in practice-building business within the hormone optimization space.

Pfizer

Market Cap: US$133.5b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Aroa Biosurgery

Market Cap: US$165.6m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Fennec Pharmaceuticals

Market Cap: US$219.0m

Operates as a commercial stage biopharmaceutical company in the United States.

Agios Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

WuXi AppTec

Market Cap: US$181.8b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.

Cellectis

Market Cap: US$98.3m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Enanta Pharmaceuticals

Market Cap: US$126.8m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Prothena

Market Cap: US$247.1m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Fortrea Holdings

Market Cap: US$389.3m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Myriad Genetics

Market Cap: US$386.2m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Planet 13 Holdings

Market Cap: US$97.6m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Sangamo Therapeutics

Market Cap: US$110.5m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Sanofi

Market Cap: US$105.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Phathom Pharmaceuticals

Market Cap: US$323.2m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Charles River Laboratories International

Market Cap: US$6.6b

Charles River Laboratories International, Inc.

Apellis Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Akebia Therapeutics

Market Cap: US$853.6m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Plus Therapeutics

Market Cap: US$6.3m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

Tsumura

Market Cap: US$367.4b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Simcere Pharmaceutical Group

Market Cap: US$13.9b

Engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China.

Shield Therapeutics

Market Cap: US$24.5m

A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.

Vetoquinol

Market Cap: US$884.7m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Travere Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Ascendis Pharma

Market Cap: US$9.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.